Does UMR cover Zepbound? Sometimes. Your employer's plan—not the UMR name on your card—sets the benefit. Check whether it covers your prescribed version and treatment reason, and whether you need prior authorization. Without coverage, Lilly's self-pay prices start at $299 per 28 days for the 2.5 mg starting dose. Sources: UMR and Lilly.
Disclosure: Some provider links on this page are marked (sponsored). If you use them, we may earn a commission at no extra cost to you. You never need a paid program to check your coverage. Your plan will answer for free. How we make money
Best for: People with UMR-administered employer benefits who have a prescription, a denial, a prior-authorization request, or a scary pharmacy price.
Not a plan-specific coverage decision: Medicare, Medicaid, and employer-retiree arrangements need their own benefit check. See special cases below.
Before you pay for anything, find out which problem you have
Sort your next step into a coverage problem, a paperwork problem, or a cost problem. Each one calls for a different response. Find yours below.
| What you've been told | What to find out first | Jump to |
|---|---|---|
| "I don't know if it's covered." | Which benefit and drug list apply to you | The coverage check |
| "It needs prior authorization." | Which rules and records your plan requires | What the plan asks for |
| "It's not covered." | Whether that means an exclusion, a denied request, or the wrong version | Denial decoder |
| "It's approved, but it's still expensive." | Your cost after the deductible, plan payment, and eligible savings | What you'll really pay |
| "My refill suddenly stopped." | The exact rejection reason and approval end date | Denial decoder |
Get my UMR Zepbound checklist → Copy or print · free · no email · no member ID
The device matters. Zepbound has single-dose pens, single-dose vials, and a four-dose KwikPen; its current label also lists a multi-dose vial. Your plan can give different answers for different versions. Ask about the exact product on your prescription—not just the word "Zepbound." Sources: Zepbound prescribing information and Optum Rx.
Your answer turns on four things:
- Your employer's current prescription benefit
- The pharmacy company printed on your card
- Which Zepbound version is on your prescription
- Why it's prescribed: weight management or obstructive sleep apnea
The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.
How we checked this page: We read UMR's own pages, UnitedHealthcare's published pharmacy-policy text, Optum Rx's July 2026 drug list and July–August change reports, Lilly's price and savings terms, and real employer plan pages. We did not log in to anyone's plan or call a plan for anyone. See what we verified—and its limits ↓
Need a different guide?
- You're on Medicare: Does Medicare Cover Zepbound?
- You're on Medicaid: Does Medicaid Cover Zepbound?
- UnitedHealthcare administers your plan rather than UMR: UnitedHealthcare Zepbound Prior Authorization. A UnitedHealthcare network logo alone does not identify your prescription benefit.
- You want compounded tirzepatide: It isn't FDA-approved Zepbound. See Compounded vs. Name-Brand GLP-1. FDA explains the difference.
Does UMR cover Zepbound in 2026?
UMR does not have one Zepbound rule. Your employer's plan may cover it with prior authorization, cover one treatment reason but not another, exclude it, or treat its versions differently. Your own benefit documents decide which answer applies. Sources: UMR, UHC, and Optum Rx.
Use these four starting points to work out your next step. They are a decision guide, not a survey of UMR plans.
| What your plan says | What it really means | Your best next step |
|---|---|---|
| 1. Covered, with prior authorization | The benefit is available, but your prescriber must show you meet the applicable rules. | Confirm the covered version, then have your prescriber submit the request. Check savings-card eligibility after you get the plan's price. |
| 2. Not covered for weight loss, but possibly covered for sleep apnea | The plan may assess diagnosed obstructive sleep apnea under a separate policy. | Ask which policy applies to that diagnosis. See the sleep apnea rules. |
| 3. Excluded under your benefit | The plan says the requested use or product is outside its benefits. | Get the exact plan wording and available exception or appeal steps before moving to cash prices or an HR request. |
| 4. Covered, but not your version | The prescription may not match the product the plan covers. | Ask which version is covered and have your prescriber decide whether a new prescription is appropriate. |
Hearing "no" is common. In KFF's 2025 employer survey, 19% of firms with 200 or more workers that offered health benefits covered GLP-1 drugs for weight loss in their largest plan. That rose to 43% of firms with 5,000 or more workers. Those are employer survey results—not UMR approval rates. A benefit exclusion is not a judgment about whether you deserve care. Source: KFF's 2025 survey.
Why online answers about UMR conflict "I am being told UMR as a whole is not approving ZB for anyone." — Reddit user Mountain_Bluebird20, r/Zepbound "We have UMR with ExpressScripts as the prescription manager, and it is covered with a PA." — Reddit user Ok-Yam-3358, same thread These are older, self-reported posts. They don't prove anyone's coverage today. They show why another member's answer cannot settle your own coverage question. Read the original discussion.
Who decides: UMR, UnitedHealthcare, Optum Rx, or your employer?
Your employer chooses the plan's benefits. UMR runs the plan and processes claims, but it is not an insurance company. The company handling your prescription benefit applies your drug list and prior-authorization rules. Sources: UMR and Pinellas County.
Here's who controls what.
| Who | What they control | What they can't promise |
|---|---|---|
| Your employer (the plan sponsor) | The benefits it offers and the companies it hires to administer them | That a covered benefit makes a drug medically right for you |
| UMR (the plan administrator) | Plan administration, claims processing, and benefit questions | One Zepbound rule that applies to every UMR employer |
| Your pharmacy company (the pharmacy benefit manager, or PBM) | Administration of your drug list, authorization rules, and prescription claims | Coverage based only on a public drug list, without checking your benefit |
| Your prescriber | Your exam, prescription, medical records, and any authorization or appeal support the office provides | Insurance approval or a change to your employer's benefits |
| Lilly (the maker of Zepbound) | Its self-pay offers, savings programs, and employer access program | A change to what your health plan covers |
Is UMR the same as UnitedHealthcare?
No. UMR is a UnitedHealthcare company, but it's a third-party administrator (TPA). A TPA is a company an employer hires to run its health plan. UMR tells members plainly that it is not an insurance company. Your employer funds the claims. Every employer's plan can be different. Source: UMR.
A UnitedHealthcare network logo does not tell you which company handles your prescriptions. Check the pharmacy information on the card and in your benefits portal.
Does UMR use Optum Rx for prescriptions?
Some UMR plans do, but not all. Don't guess. Here's a real example. Pinellas County, Florida runs its medical plan through UMR, but its drug plan is run by Express Scripts. The county tells members to use their UMR card, which includes the Express Scripts information. Source: Pinellas County.
So flip your card over. Ask the pharmacy company named there for the rules attached to your employer's plan.
- Optum Rx → keep reading. The version table below is built on Optum's standard Premium list.
- Express Scripts → also see Express Scripts Zepbound Prior Authorization.
- CVS Caremark → also see CVS Caremark Zepbound Prior Authorization.
Why your state's coverage rules may not apply
Self-funded private-employer plans generally are not subject to state insurance benefit mandates. A federal law called ERISA governs many of those plans. Government and most church plans follow different rules. The UMR name alone does not tell you which legal protections apply. Sources: Texas Department of Insurance and DOL.
Ask: "Is our plan self-funded, and is it covered by ERISA?" That answer helps you find the right benefit rules and appeal process.
Your situation changes the answer. The right GLP-1 provider isn't the same for everyone. It depends on your state, your insurance and formulary, whether you want an FDA-approved or compounded medication, your preferred treatment path (injection or oral), and your budget. Because a general answer can't resolve those for you, use The RX Index's Find My GLP-1 Path tool to explore provider options before you choose. Your plan still needs to confirm your own coverage and cost.
How do I check if my UMR plan covers Zepbound?
Call the pharmacy phone number on your member card. Ask whether Zepbound is covered with prior authorization, excluded, or subject to an exception—and name the exact version on your prescription. Ask for the applicable rules in writing and save a reference number. Sources: Pinellas County and DOL.
A drug list tells you where to look. Your own plan tells you whether that list applies to you. Here's how to get your own answer.
Step 1: Flip your card over
Look for the pharmacy section. Write down:
- The pharmacy company name (Optum Rx, Express Scripts, CVS Caremark, or another)
- The pharmacy phone number (it's often different from the medical line)
- The member website or app
No pharmacy info on the card? Call the main number and ask, "Who handles my prescription benefit?"
Step 2: Search the exact Zepbound version
Log in to the pharmacy company's app or website. Search "Zepbound." If it shows more than one version, check each one:
- Zepbound single-dose pen
- Zepbound KwikPen
- Zepbound vial, including whether the prescription says single-dose or multi-dose
For each, note: covered or not, the tier (the price level), whether it needs prior authorization, and any quantity limit. If the names are unclear, ask the pharmacy to check the exact product code, called the NDC, on your prescription or claim. Sources: Zepbound prescribing information and Optum Rx.
Step 3: Search your plan's rulebook
For an ERISA plan, start with the Summary Plan Description (SPD) and any later benefit changes. HR or the plan administrator can send them. For a government plan, ask for its current benefit booklet and exclusions. Open the document, press Ctrl+F (Cmd+F on a Mac), and search: weight loss, obesity, anti-obesity, weight reduction, exclusions. Save the exact page that answers your question. Source: DOL.
Step 4: Ask the one question that matters most
"Is Zepbound a covered benefit that needs prior authorization, or is it excluded from my plan?"
A prior authorization request asks whether you meet the plan's rules. An exclusion asks whether the benefit exists at all. More paperwork alone does not solve every denial. Knowing which question you're facing tells you what to do next. Sources: UMR, DOL, and UHC.
Step 5: Use this call script, and save the answer
Copy this and read it on the call:
"Hi, I have a UMR plan and I'm checking coverage for Zepbound under my prescription benefit. 1. Who manages my prescription coverage? 2. Is Zepbound covered, excluded, or non-formulary? 3. Which version is covered: the single-dose pen, the KwikPen, or a specific vial product? 4. Is it covered for weight management, for obstructive sleep apnea, or both? 5. Does it need prior authorization? Please send me the criteria that apply to my group. 6. Are there quantity limits, required programs, required prior treatments, or a required pharmacy? 7. What would I pay for one fill, before and after my deductible? Please send this to my member portal, and give me a reference number."
Write down: the date, the rep's name, the reference number, the answer to each question, and what happens next. Keep the call log with the written response. A phone quote is not a guarantee that a later claim will be paid.
Your copyable UMR Zepbound checklist
Copy this into a note or print it. Keep your completed copy private; you do not need to send it to The RX Index.
| What to save | Your answer |
|---|---|
| Employer plan name and benefit year | ____________________ |
| Pharmacy company and phone number | ____________________ |
| Prescribed Zepbound version and dose | ____________________ |
| Covered, excluded, or exception needed? | ____________________ |
| Policy name, program number, and effective date | ____________________ |
| Required records or steps still missing | ____________________ |
| Pharmacy price before and after any eligible savings | ____________________ |
| Authorization end date or appeal deadline | ____________________ |
| Person or office handling the next step | ____________________ |
| Call date and reference number | ____________________ |
Leave unknown answers blank. The goal is to find the next unanswered question, not to guess whether you qualify.
Don't want to make the call? Ro can check the pen for you
Ro's free GLP-1 Insurance Coverage Checker contacts your plan for you. You get a report that shows whether the Zepbound pen is covered and whether it needs prior authorization. It doesn't write a prescription or submit anything for treatment. Ro also advertises a $50 treatment credit for new accounts; that is not a cash payment or a promise of coverage. Source: Ro's checker page.
The one thing to know: Ro's checker does not check the Zepbound KwikPen, and its listed Zepbound option is the pen—not a vial coverage check. If the KwikPen or a vial is your priority, calling your plan yourself with the script above is the better move. But the report does check the single-dose pen, which can be covered under Optum Rx's standard Premium list when the plan's benefit allows it. And Ro makes the call for you. Sources: Ro and Optum Rx.
Check my Zepbound pen coverage free with Ro → (sponsored) Free report · Ro contacts your plan · no prescription needed
Is your prescription for the KwikPen? Check that exact product with your plan, then compare what Zepbound costs if your plan says no.
Which Zepbound does your UMR plan cover: pen, KwikPen, or vial?
If your UMR plan uses Optum Rx's standard Premium drug list, the single-dose pen is listed at Tier 2 with prior authorization and a quantity limit. The KwikPen and vial entries are Tier E, or excluded. Your employer's benefit and any approved exception still control the final answer. Source: Optum Rx's July 1, 2026 Premium list.
We built this comparison from Optum Rx's drug list, Lilly's price terms, and Lilly's employer program. It separates a formulary listing from a price offer—two things a coverage search can easily mix up.
| Coverage or payment path | Single-dose pen | KwikPen: 4 doses in 1 pen | Single-dose vial |
|---|---|---|---|
| Optum Rx Premium standard list, July 1, 2026 | Tier 2 · prior authorization · quantity limit · "++" | Tier E: excluded | The subcutaneous-solution entry is Tier E: excluded; confirm the exact vial product |
| LillyDirect self-pay offer | Not the $299–$449 KwikPen/vial offer | $299 at 2.5 mg; $399 at 5 mg; $449 at higher doses under the purchase offer | Same dose-based offer prices |
| Commercial savings card when insurance covers the single-dose pen | As low as $25 per 28-day fill, subject to savings limits | Not this offer | Not this offer |
| Commercial savings card when insurance does not cover Zepbound | As low as $499 per 28-day fill | As low as $299–$449, with dose, savings, and refill conditions | Not this commercial card offer |
| Lilly Employer Connect | Not the announced product | Lilly's price to participating network pharmacies is $449 at every dose; employee cost depends on the program | Not the announced product |
Sources checked September 22, 2026: Optum Premium list, Lilly prices and card terms, and Employer Connect launch. The label also includes a multi-dose vial; the single-dose-vial prices above are not a verified quote for that product.
What the codes mean. On Optum Rx lists, "++" means coverage is decided by your prescription benefit plan. In plain words, the public listing does not settle your employer's benefit. "Tier E" means excluded. The booklet also describes how to request a coverage exception. Source: Optum Rx's code key and exception instructions.
Here's the catch: the KwikPen has a published $299–$449 self-pay offer, yet it is excluded on this standard Optum list. The product your plan lists and the product with that cash offer can be different. That gives you two prices to compare—not a reason to assume cash is cheaper.
- Insurance path: the covered version, any required prior authorization, and an eligible savings card.
- Cash path: the prescribed version under the specific self-pay or savings offer you qualify for.
Other plans can flip this. On July 1, 2026, the University of Minnesota's plan, using Prime Therapeutics rather than UMR, moved weight-management coverage from Zepbound pens and vials to the KwikPen. Members needed a new prescription and separate pen needles. Same medicine, opposite device preference. That's why you always ask by version. Source: the university's coverage update.
Two more practical notes:
- Optum's July 2026 Premium authorization list specifies 4 Zepbound single-dose units every 28 days. Confirm your plan's quantity limit rather than applying that number to every version. Source: Optum Rx.
- The KwikPen needs pen needles, sold separately. Single-dose vials need separate injection supplies too. The lowest advertised price, $299, is for the 2.5 mg starting dose, not a maintenance dose. Sources: LillyDirect and Zepbound prescribing information.
Use my doctor's Zepbound checklist → The version to confirm, the policy to request, and the records to gather. Free, no email.
What does a UMR plan need for Zepbound prior authorization?
There is no single UMR rule. UnitedHealthcare publishes an optional weight-loss program with a BMI threshold of 30, or 27 with a weight-related health problem, plus lifestyle changes. Under that program's general Zepbound criteria, the first approval lasts 6 months and renewal requires at least 5% weight loss. Source: UHC's weight-loss program.
Prior authorization (PA) means your prescriber must show that you meet the plan's coverage rules before it will pay. BMI means body mass index, a number based on height and weight. Your plan may use its own rules. Ask for the policy attached to your group—not just a UnitedHealthcare PDF found online.
UnitedHealthcare's weight-loss program for Zepbound
The posted policy text identifies Program 2026 P 1114-22, effective September 1, 2026. UnitedHealthcare describes it as optional for clients that elect weight-loss drug coverage. The table below summarizes its general Zepbound criteria, not every employer's benefit.
| Rule | What the program says |
|---|---|
| Age | The multi-drug policy lists an age above 16 for its "other medications" group, which includes Zepbound. Zepbound's FDA-approved uses are for adults. Do not treat this policy wording as pediatric FDA approval. |
| BMI | 30 or higher, or 27 or higher with a weight-related problem such as high blood pressure, high cholesterol, type 2 diabetes, or sleep apnea |
| Lifestyle | Used alongside lifestyle changes such as diet, exercise, or behavior support. This section does not set a minimum number of months of prior participation. |
| First approval | 6 months |
| Renewal | At least 5% weight loss from baseline, plus continued lifestyle changes |
| Renewal length | 12 months |
Sources: UHC's general coverage criteria and Zepbound prescribing information. Confirm your benefit and applicable policy before filing.
What 5% looks like: If your plan's recorded baseline is 220 pounds, 5% is 11 pounds. Confirm which dated weight the plan will use before the renewal request.
What your prescriber should send
Hand this list to your doctor's office, along with the criteria your plan sent you.
| Item | What it helps answer |
|---|---|
| Height, weight, and BMI, with dates | Whether the records show the required starting point and any change since treatment began |
| Weight-related conditions already in your chart | Whether you meet the extra condition requirement when the applicable BMI rule calls for it |
| A note about diet and activity changes | How the request meets the policy's lifestyle requirement |
| The exact Zepbound version and dose | Whether the request matches the prescription and drug-list entry |
| Your prior denial, if this is a second try | Which reason needs to be addressed |
| The submission date and reference number | So you can track it |
This checklist organizes the request; it does not replace the plan's criteria or the prescriber's judgment. Sources: UHC and Lilly.
Never change or add a diagnosis to get approved. A clean, true record is your best request.
How long will prior authorization take?
For most private-employer plans covered by ERISA, the normal deadline for a pre-service decision is 15 calendar days after the plan receives the claim. A permitted extension can add up to 15 days with notice, and requests for missing information affect the clock. A medically urgent claim generally must be decided as soon as possible, no later than 72 hours. Urgency is based on the medical situation, not a wish for faster processing. Government employer plans can follow different rules. Source: DOL's claims guidance.
Ask your pharmacy company for the date it received the request, what is still missing, and the decision deadline it is using.
For the UnitedHealthcare criteria, see UnitedHealthcare Zepbound Prior Authorization. For Optum Rx forms and submission steps, see OptumRx Zepbound Prior Authorization.
Can UMR cover Zepbound for sleep apnea if weight loss is excluded?
Possibly. Zepbound is FDA-approved for moderate-to-severe obstructive sleep apnea in adults with obesity. UnitedHealthcare publishes a separate coverage program for that use when weight-loss drugs are excluded. Your UMR-administered plan must actually use that benefit and policy for it to help you. Sources: FDA and UHC.
Obstructive sleep apnea (OSA) is when your airway keeps closing during sleep, so your breathing stops and starts. PAP means positive airway pressure; CPAP is one type of PAP treatment that helps keep the airway open during sleep. The FDA approved Zepbound for OSA on December 20, 2024. Source: FDA.
If your plan already covers weight-loss drugs, first ask whether its general Zepbound policy applies. Do not assume the stricter, separate OSA-only program below applies to every request involving sleep apnea. Source: UHC's policy cross-reference.
UnitedHealthcare's sleep-apnea-only program for Zepbound
The posted policy text identifies Program 2026 P 1475-3, effective September 1, 2026. These are requirements to discuss with your prescriber when your plan uses that program.
| Rule | What the program asks for |
|---|---|
| Age | 18 or older |
| BMI | 30 or higher |
| Sleep study | Records confirming moderate-to-severe OSA. Send the full report with the apnea-hypopnea index (AHI), respiratory event index (REI), or respiratory disturbance index (RDI). |
| Diet history | At least one past diet attempt that did not work |
| PAP history | Continued OSA symptoms despite PAP use of at least 4 hours a night on at least 70% of nights, or a documented reason the patient is not a candidate for PAP |
| Current treatment plan | Reduced-calorie diet and increased physical activity |
| Diabetes and lab records | No diabetes diagnosis; the policy also applies a limit for A1c, a blood sugar test. Have the prescriber check the actual lab report against the current policy. |
| Counseling | Advice on sleep position and avoiding alcohol or sedatives before bed |
| Other exclusions | No planned surgery for OSA or obesity, and no predominant central or mixed sleep apnea |
| Prescriber | A sleep medicine, lung, or ear-nose-throat specialist; a physician experienced in OSA; or prescribing in consultation with one of them |
| First approval | 6 months |
Source: UHC's OSA-only policy. This is a records checklist, not a complete eligibility test. Have the prescriber match the exact sleep-study and A1c cutoffs in your current group policy before submitting.
What does the sleep apnea program require at renewal?
The September policy text requires at least 10% weight loss from baseline, continued diet and activity changes, continued need for OSA treatment, and the policy's diabetes/A1c requirement. The sleep-study requirement then depends on PAP use and time on treatment. Source: UHC's reauthorization section.
| Situation at renewal under this program | Sleep-score evidence | Renewal length |
|---|---|---|
| Using PAP; less than 52 weeks on Zepbound | No separate sleep-score improvement requirement in this branch | 6 months |
| Using PAP; 52 weeks or more on Zepbound | No separate sleep-score improvement requirement in this branch | 12 months |
| Not using PAP; less than 52 weeks on Zepbound | A decrease from baseline in AHI, REI, or RDI | 6 months |
| Not using PAP; 52 weeks or more on Zepbound | A 50% decrease from baseline in AHI, REI, or RDI | 12 months |
The 10% weight-loss and other renewal requirements still apply to every row. Source: UHC.
Here's the honest part. This program asks for double the weight loss to renew compared with the general weight-loss program above: 10% instead of 5%. If your recorded baseline is 220 pounds, that's 22 pounds, not 11.
What changed this year: The policy's June 2026 update, effective September 1, removed the separate sleep-score improvement requirement for PAP users and widened the prescriber list. It did not remove the 10% weight-loss rule. Source: UHC's change history and renewal criteria.
Please don't treat sleep apnea as a trick. This path is only for people who truly have it. Never stop using a prescribed CPAP to "qualify." Never ask for a diagnosis you don't have. If you think you might have sleep apnea, talk to your doctor about an assessment because it matters for your health, not just your coverage.
Have type 2 diabetes? This specific UHC OSA-only program excludes diabetes. That is an insurance-program restriction, not an FDA ban on Zepbound for everyone with diabetes. Mounjaro is Lilly's tirzepatide medicine approved for type 2 diabetes. Ask your clinician which treatment fits and check its own coverage rules. See UnitedHealthcare Mounjaro Prior Authorization and OptumRx Mounjaro Prior Authorization. Sources: UHC, Zepbound prescribing information, and Mounjaro prescribing information.
How much does Zepbound cost with UMR?
There's no single UMR price. Eligible commercially insured patients with covered single-dose pens may pay as little as $25, but the card's savings cap matters. Without coverage, Lilly has separate pen, KwikPen, and single-dose-vial offers. The $299–$449 range is conditional—not a price cap for every prescription. Source: Lilly's price and savings terms.
Here's how the payment paths compare. Medication prices below are for a 28-day supply and do not include a separate care membership.
| How you pay | Published medication price | The catch |
|---|---|---|
| Covered single-dose pen + eligible commercial savings card | As low as $25 | Savings are capped at $100 per 28-day fill and $1,300 per calendar year, for up to 13 fills. A higher amount due can leave you paying much more than $25. |
| Uncovered single-dose pen + eligible commercial savings card | As low as $499 | Commercial insurance and the card's other eligibility rules apply; up to 13 fills per calendar year. |
| LillyDirect self-pay: KwikPen or single-dose vials | $299 at 2.5 mg; $399 at 5 mg; $449 at 7.5–15 mg under the purchase offer | The first higher-dose purchase gets the offer. Keeping it requires a refill purchase within 45 days of the previous delivery or receipt. Without it, regular prices are $499 at 7.5 mg and $699 at 10–15 mg. |
| KwikPen savings card | As low as $299–$449, depending on dose and offer eligibility | Lilly has commercial-insurance and separate self-pay card terms. KwikPen cards allow up to 11 fills per calendar year; higher-dose pricing has the refill condition. |
| Lilly Employer Connect | No universal employee price | Lilly's $449 figure is its price to participating network pharmacies. Your bill depends on employer support, program design, and any fees. |
| Approved OSA claim | The cost under your own prescription benefit | The OSA indication does not create a universal copay or tier. Get a pharmacy quote. |
Sources checked September 22, 2026: LillyDirect prices, full savings and purchase terms, and Employer Connect. Lilly's listed card programs expire December 31, 2026, subject to changes in their terms. Eligibility, savings caps, taxes, fees, and injection-supply costs can affect the final bill.
The $299 dose is the starting dose. Zepbound's 2.5 mg dose is not a maintenance dose. Budget for the dose your clinician expects you to use, not just the first advertised price. Source: prescribing information.
Why "$25" may not be your number
Say your plan charges you $300 for a covered fill because you haven't met your deductible. The card takes off up to $100. You'd pay about $200 that month, not $25. (This is an example to show the math. Your plan's price will differ.) Card limit: Lilly.
Real UMR plans show how wide the range is. On Pinellas County's UMR-administered medical plan with Express Scripts prescription benefits:
- PPO: preferred brand drugs cost 20%, with a $30 minimum and $60 maximum per 30-day supply.
- High-deductible plan: members pay the full contracted price until the deductible is met, then 20%.
- Coupons: only what you pay out of your own pocket counts toward the deductible, not what the coupon covers.
Those are the county's general prescription benefits, not proof that its plan covers Zepbound or assigns it a specific tier. Same UMR name, very different bills. Ask your plan for the price of your exact fill. Source: Pinellas County.
Why these self-pay offers don't help your deductible
The self-pay programs described here operate outside insurance. Ro's LillyDirect terms and Lilly's separate KwikPen Self-Pay Savings Card terms bar applying those purchases to insurance deductibles or out-of-pocket requirements. This is a rule of those offers—not a claim that every cash prescription purchase under every plan can never count. Sources: Ro's LillyDirect terms and Lilly's self-pay card terms.
If you're close to meeting your deductible, compare both options before you pay cash.
Paying with an HSA or FSA? A prescribed medication can be a qualified medical expense, but the payment program's terms matter too. Lilly's separate KwikPen Self-Pay Savings Card bars reimbursement from a healthcare reimbursement account. Check the exact offer with the program and your account administrator before using HSA/FSA funds or seeking reimbursement. Never claim an amount paid by a coupon as your own expense. Sources: IRS Publication 502, IRS Publication 969, and Lilly.
See Zepbound HSA/FSA Eligibility. For more dose-by-dose math, see Zepbound Cost With Insurance and Zepbound Self-Pay Price.
Do you need Ro or another program to get Zepbound with UMR?
No. Your current clinician can assess you for Zepbound, and the office may handle prior authorization. You can check your coverage yourself for free. A paid program helps when you need a prescriber, want insurance-paperwork support, or want ongoing care while paying cash. Sources: Lilly and Ro.
Let's be straight. No paid program can promise to make an excluded plan cover Zepbound. It can help check the benefit, correct an error, or support an available appeal. It cannot sell you a new benefit. If you have a doctor who will handle the paperwork, you may not need anyone else.
Paid help earns its keep in three cases:
- You need a prescriber who works with brand-name GLP-1s.
- You want someone to handle the prior authorization for you.
- Your plan says no, and you want a brand-name self-pay option plus ongoing care.
Before you start any GLP-1: safety basics. Zepbound has a boxed warning about thyroid C-cell tumors seen in rats. It's not known if it causes them in people. Do not use it if you or your family have had medullary thyroid cancer, if you have multiple endocrine neoplasia type 2 (MEN 2), or if you have had a serious allergic reaction to tirzepatide or another Zepbound ingredient. Other warnings include pancreatitis, gallbladder problems, kidney problems from dehydration, and low blood sugar when used with certain diabetes drugs. Source: prescribing information.
Zepbound can also make birth control pills work less well. The label advises switching to a non-oral method or adding a barrier method for 4 weeks after starting and 4 weeks after each dose increase. Stop Zepbound and contact your clinician if you become pregnant. The label does not recommend combining Zepbound with another tirzepatide product or a GLP-1 medicine. Read the prescribing information and talk it through with a clinician.
Ro: our pick for insurance help with brand-name Zepbound (sponsored)
Why Ro fits this page: it lists FDA-approved GLP-1 options, offers insurance support, and publishes Zepbound KwikPen self-pay prices that match the Lilly offer shown above. That's our reason for featuring it—not a claim that a membership improves your odds of approval. Sources: Ro pricing and Ro insurance support.
- Coverage: Ro's insurance concierge checks your benefits and, when prior authorization is needed, submits the paperwork for you. Ro estimates about 2–3 weeks for its insurance process; that is a provider estimate, not a guaranteed approval time.
- If you're not covered: Ro lists the Zepbound KwikPen at $299 at 2.5 mg, $399 at 5 mg, and $449 at 7.5–15 mg under Lilly's offer. Ro also lists Foundayo. Medicine is separate from membership.
- Membership: Get started for $39, then as low as $74/month with an annual plan paid upfront, or $149 month to month. Ro advertises a refund if you are not eligible for treatment. Its terms say that if medication is never prescribed, the purchase price is refunded and the recurring membership does not start. An insurance denial is not the same as medical ineligibility.
- What Ro can't do: promise approval, or override your plan.
Provider-stated services and prices checked September 22, 2026: Ro pricing, how it works, and membership terms. We did not enroll, submit a PA, or test an outcome.
Know when billing starts. Ro's terms say membership begins when the provider writes a prescription and communicates the care plan. Charges can continue even if you do not request or receive medication. Paid membership fees are generally nonrefundable; cancel at least 48 hours before renewal to avoid the next charge. Check the amount due upfront before choosing an annual plan. Source: Ro's terms.
What does Ro cost after you add the medicine?
Here is the math for one membership charge plus one 28-day KwikPen fill. These are examples using Ro's published prices, not quotes for your treatment.
| Example | Care charge | Medication fill | Combined amount |
|---|---|---|---|
| First care month plus the 2.5 mg starting-dose fill | $39 | $299 | $338 |
| Month-to-month care plus a 5 mg fill | $149 | $399 | $548 |
| Month-to-month care plus a 7.5–15 mg fill under Lilly's offer | $149 | $449 | $598 |
Our calculations from Ro's published prices. Injection supplies, applicable taxes, fees, and extra services are not included. A 28-day medication fill and a membership billing month need not start or end on the same day. The annual membership's lower monthly equivalent requires upfront payment.
"Within two days, Ro ran my prior authorization and guided me to a savings card." — Alyssa, a paid Ro partner, quoted in Ro's coverage-checker report. This describes one person's paperwork experience, not a promised timeline or result. Read the attributed testimonial.
Start Ro's $39 clinical assessment → (sponsored) Refund terms depend on treatment eligibility—not insurance approval. Medication costs extra.
Sesame: if you'd rather pick your own clinician (sponsored)
Sesame lets you browse clinicians, read reviews, and book directly. Its dedicated weight-loss program advertises help with medication prior authorization. Before you book, confirm the clinician will help with your plan's request; do not assume a general one-off visit includes that service. Source: Sesame's weight-loss program.
Sesame advertises $99 every 28 days, or care from $59/month with an annual subscription paid upfront. Some clinicians charge more. Medicine costs extra. Its policy offers a full refund when you cancel at least 3 hours before the initial visit; the first month is not refundable after that visit. Cancel before the next billing cycle to avoid renewal. Source: Sesame's pricing and refund terms.
Sesame is also one of the independent program administrators named in Lilly's Employer Connect launch. Booking a Sesame visit does not enroll your employer in Employer Connect. Those are separate decisions. Source: Lilly's administrator list.
Compare Sesame's weight-loss clinicians and care prices → (sponsored)
Quick comparison
| Option | Checks your coverage | Handles prior authorization | Cost to you | Best fit |
|---|---|---|---|---|
| Your current doctor | You can start by calling the plan | Ask whether the office provides this service | Your usual visit cost, plus medicine | Anyone with a doctor who'll do the paperwork |
| Ro (sponsored) | Free report for the Zepbound pen | Insurance concierge for its clinical program | $39 introduction, then $149 month to month or a lower prepaid equivalent; medicine separate | People who need a clinician and want insurance support or a branded cash-pay option |
| Sesame weight-loss program (sponsored) | Confirm the process with the program | Advertised as included support | Advertised $99 per 28 days or from $59/month with annual prepayment; provider prices can be higher; medicine separate | People who want to choose their own clinician |
| LillyDirect self-pay fulfillment | The self-pay purchase is outside insurance | Bring a prescription; fulfillment itself is not a PA service | Dose-based medicine price plus supplies and any fees | People with a prescription who'll pay cash |
Service descriptions come from Ro, Sesame, and LillyDirect. The "best fit" column is our editorial judgment, not a clinical-quality ranking or a promise of coverage.
Why no compounded options here? This page is about getting FDA-approved Zepbound through your UMR plan or a branded self-pay program. Compounded tirzepatide is not FDA-approved Zepbound. A benefit for Zepbound does not establish coverage for a compounded preparation. For the differences between the two, read Compounded vs. Name-Brand GLP-1. Source: FDA.
Why did UMR deny Zepbound, and how do you fix it?
First find out what kind of "no" you got: an excluded benefit, missing paperwork, rules not met, or the wrong Zepbound version. Match the response to the written reason. Don't give up an appeal right just because a pharmacy screen says "not covered." Source: DOL's denial and appeal guidance.
Match your message to the next step.
| What you see | What it may mean | Who to contact | Your next move |
|---|---|---|---|
| "Prior authorization required" | Your plan may cover it, but wants a request first | Your prescriber | Ask the office to file it. Get the reference number. |
| "Missing information" | The request was incomplete | Your prescriber and plan | Ask what is missing and how to send it. If a formal denial has already been issued, keep its appeal deadline. |
| "Criteria not met" | The plan says the records did not meet its rules | Prescriber and plan | Compare the denial with the criteria. Ask about an appeal, corrected records, or a medical-necessity exception where available. |
| "Product not covered" or "non-formulary" | The product is not routinely covered, or the prescription does not match the listed version | Prescriber and pharmacy company | Ask which version is covered and whether an exception is available. |
| "Plan exclusion" | The plan says the requested benefit or product is excluded | Plan administrator and prescriber | Get the exact wording, check available review rights, and ask whether another covered indication truly applies. |
| "Approved," but the price is high | Deductible, coinsurance, product mismatch, or another claim issue | Plan and pharmacy | Ask for the price breakdown before applying an eligible savings card. |
| Refill suddenly rejected | The approval ended, the dose changed, you hit a quantity limit, or the benefit changed | Pharmacy and prescriber | Ask for the exact reason and your approval end date. |
This is a troubleshooting guide, not a diagnosis of an individual claim. Sources: DOL, Lilly's access guidance, and Optum's drug-list instructions.
Your rights if you're denied
For most private-employer plans, federal rules under ERISA give you real rights:
- The denial must explain itself. It must give the specific reason and the plan provision used.
- You can get relevant documents free. Ask for the records, rules, and other information relevant to the decision.
- You get at least 180 days to file the initial appeal. A required second appeal can have a different deadline.
- A pre-service appeal generally must be decided within 30 days. If there are two mandatory review levels, each generally gets 15 days. Urgent appeals generally have a 72-hour limit.
- Non-grandfathered plans have additional external-review requirements for qualifying denials. Medical-judgment disputes are different from a pure contract exclusion; ask which review process applies.
Plans run by governments and most religious groups can follow different rules. Check the notice and your plan's appeal procedure. If a deadline or process does not make sense, ask for help rather than assuming you have lost your rights. Sources: DOL and HealthCare.gov.
Need help with a private-employer ERISA plan? Contact the Department of Labor's Employee Benefits Security Administration at 1-866-444-3272. Source: DOL.
Copy this records request:
"Please tell me the exact plan rule or clinical criterion used to deny my Zepbound request, and send me free copies of the documents used in the decision, plus instructions and the deadline for an appeal."
What public records show about exclusions
On February 25, 2026, Michigan's insurance regulator upheld a Zepbound denial under a government employer's self-funded plan administered through Optum Rx. The plan classified the drug as excluded for the request under review. That was not a UMR plan. Source: Michigan DIFS, case 243954.
But the decision also noted that the member could submit a new PA request with records about coronary artery disease. That footnote did not promise coverage or add a new FDA-approved use for Zepbound. It shows why the full decision matters: an upheld denial can still identify another review step. Sources: Michigan's decision and Zepbound's label.
The lesson: get the exact exclusion and ask what can still be reviewed. Do not pay someone who promises to defeat every exclusion, and do not assume every appeal is pointless. If the benefit remains excluded after that check, compare self-pay options and the employer request below.
Get the free appeal letter for my denial type → Use the template that matches your written denial. Keep the facts true and follow your plan's filing instructions.
Can you get your employer to cover Zepbound next year?
You can ask your employer to consider adding coverage or another access benefit. Lilly's Employer Connect is one option: it gives participating network pharmacies a $449 KwikPen price at every dose, with employee costs shaped by employer support and program fees. It is not a guaranteed $449 employee bill. Sources: UMR and Lilly.
With a self-funded UMR plan, your employer helps design the benefit. That gives you a specific place to send a request.
What is Lilly Employer Connect?
Lilly launched Employer Connect on March 5, 2026. Here's how it works:
- Lilly announced a $449 price to participating network pharmacies for the Zepbound KwikPen at every dose.
- Employers work through independent program administrators. The launch list included GoodRx, Mark Cuban's Cost Plus Drug Co., Sesame, Teladoc Health, Transcarent, and others.
- Employer support and program design affect what workers pay.
- Extra dispensing, pharmacy, or service fees may apply.
It gives HR another access option to price and compare. It does not mean your employer has joined, and it does not make the medicine free. Source: Lilly's launch announcement.
One comparison worth asking HR to make: the $449 program medicine price is $150 above Lilly's $299 starting-dose self-pay price and $50 above its $399 5 mg price, before any employer contribution or fees. Those are our calculations, not employee quotes. Ask for your actual net cost by dose, not just the headline program price. Sources: LillyDirect and Employer Connect.
When to ask
Ask HR before next year's benefits are finalized, not just when open enrollment begins. Use this question: "When do you choose next year's prescription benefits, and when should employees send requests?" Do not assume your employer uses a January 1 plan year or an October–November decision window.
What to send HR
Copy this into an email and change the plan-year detail if needed:
Hi [HR name], I'm on our UMR medical plan, and our prescription benefit doesn't cover Zepbound for weight management. For the 2027 plan year, would you consider either (1) covering FDA-approved obesity medicines with prior authorization, or (2) offering access through Lilly's Employer Connect program? Lilly announced a $449 KwikPen price to participating network pharmacies at every dose. Employee costs depend on employer support and any program fees. Could you compare the actual employee cost by dose and let us know when benefit requests are considered? Lilly's employer information Thank you, [Your name]
You don't have to share personal health details to make a general benefit request. You're asking about a benefit, not asking HR to decide your treatment.
Send the request to your benefits contact. Keep the reply with your plan notes.
What changes if I have diabetes, need teen coverage, or change plans?
These situations need a separate check. A diabetes diagnosis does not guarantee Mounjaro coverage. Zepbound's approved uses are for adults. COBRA, Medicare, and a new plan year each raise different benefit questions, so do not assume an old approval settles the next prescription. Sources: Zepbound's label, CMS, and Michigan case 244942.
I have type 2 diabetes
Mounjaro is Lilly's tirzepatide medicine approved for type 2 diabetes. Ask your prescriber whether it fits your treatment needs, then check its own formulary and PA rules. The separate UHC OSA-only Zepbound program described above excludes diabetes; that restriction is not a rule for every UMR Zepbound benefit. Sources: Mounjaro's label and UHC.
See UnitedHealthcare Mounjaro Prior Authorization.
Can my teenager get Zepbound through my UMR plan?
Zepbound's FDA-approved uses are for adults. UnitedHealthcare's multi-drug weight-loss program includes an age-above-16 category, but that does not change Zepbound's label. Your teen's doctor and plan need to resolve the treatment and coverage questions separately. Wegovy injection has an obesity indication for patients age 12 and older; that does not apply to every Wegovy form. Sources: Zepbound's label, Wegovy's label, and UHC.
See Wegovy for Teens: Insurance Coverage.
I'm leaving my job or starting COBRA
COBRA generally continues the coverage available to similarly situated plan members. Benefit changes can still apply, and the charge can generally reach 102% of the full plan cost, including the share your employer used to pay. Ask whether your prescription benefit and existing authorization remain in place. Source: CMS's COBRA guidance.
See Does COBRA Cover Wegovy? for the continuation-coverage process; check Zepbound's own benefit separately.
I'm turning 65 or I'm a retiree on Medicare
From July 1, 2026 through December 31, 2027, the Medicare GLP-1 Bridge offers qualifying beneficiaries certain weight-management medicines for a $50 copay. For Zepbound, it includes the KwikPen, not the single-dose pen or vial. It operates outside the usual Part D payment flow and has its own eligibility and PA rules. Source: CMS.
Not everyone with Part D qualifies. Prescriptions for uses eligible for ordinary Part D coverage, such as Zepbound for qualifying OSA, need the Part D coverage check instead. See Medicare GLP-1 Bridge. Source: CMS provider guidance.
I was approved last year, and my plan changed January 1
Approvals don't always survive a benefit change. In a March 25, 2026 Michigan decision involving another Optum Rx-administered plan, an open-enrollment notice said weight-loss GLP-1 approvals would end December 31. A PA letter extending into the new year did not override the changed benefit. This was one plan's dispute, not a universal UMR rule. Source: Michigan DIFS, case 244942.
Read your open enrollment notice for any GLP-1 change, and ask about your approval before the plan year ends.
I'm on compounded tirzepatide and want brand Zepbound through UMR
Your prescriber will need to write for FDA-approved Zepbound and meet your plan's rules. Ask whether the plan will review the request as initial treatment or continuation, and which starting-weight and treatment records it needs. Do not assume prior compounded use either guarantees renewal status or forces a brand-new clinical baseline. Source: the applicable initial and renewal framework.
See How to Switch From Compounded Tirzepatide to Zepbound.
FAQ: UMR and Zepbound
The UMR name does not tell you the covered drug, the price, or the renewal rule. Match your employer benefit, pharmacy company, prescription, and treatment reason before paying for a program. Sources: UMR and Optum Rx.
Is UMR the same as UnitedHealthcare?
No. UMR is a UnitedHealthcare company that works as a third-party administrator, running self-funded plans for employers. It is not an insurance company. Your employer chooses the plan's benefits. Source: UMR.
Does UMR use Optum Rx?
Some UMR plans use Optum Rx, but not all. For example, Pinellas County's UMR plan uses Express Scripts for prescriptions. Check the pharmacy section on the back of your card. Source: Pinellas County.
Does UMR cover Zepbound for weight loss?
A UMR-administered plan can cover it when that benefit is included and you meet the applicable rules. The UMR name alone does not establish coverage. Ask whether your plan covers the prescribed product and requires PA. Sources: UMR, DOL, and UHC.
Does UMR cover the Zepbound KwikPen?
It depends on your benefit and drug list. On Optum Rx's standard Premium list dated July 1, 2026, the KwikPen is Tier E, or excluded, while the single-dose pen is Tier 2 with PA, quantity limits, and benefit-design restrictions. Check any exception process and your own plan's listing. Source: Optum Rx.
Do I need diabetes to get Zepbound covered?
No. Zepbound is approved for weight management in adults with obesity, or adults with overweight and at least one weight-related health problem. It is also approved for moderate-to-severe OSA in adults with obesity. It is not approved as a diabetes treatment. For type 2 diabetes, Mounjaro is the tirzepatide medicine approved for that purpose. Coverage still depends on your plan. Sources: Zepbound prescribing information and Mounjaro prescribing information.
What BMI does UMR need for Zepbound?
There's no single UMR number. Under the general criteria in the optional UHC weight-loss program described above, the threshold is BMI 30, or BMI 27 with a weight-related condition. Ask your plan which policy applies; do not substitute that example for your own requirements. Source: UHC.
How long does a UMR Zepbound approval last?
Under the general Zepbound criteria in UHC's optional weight-loss program, the first approval lasts 6 months. Renewals require at least 5% weight loss and continued lifestyle changes, then last 12 months. A different policy or benefit can give a different answer. Source: UHC.
How long does prior authorization take?
For most private-employer ERISA plans, a pre-service request generally has a 15-calendar-day decision limit, with permitted extensions and missing-information rules. Medically urgent requests generally have a 72-hour limit. Ask when your request was received and which deadline applies. Source: DOL.
Does UMR cover Zepbound for sleep apnea?
Some plans may cover that use even when they exclude weight-loss drugs. The separate UHC OSA-only program described above has its own sleep-study, PAP, diabetes, and renewal rules. Under that program, renewal requires at least 10% weight loss; patients not using PAP also need sleep-score improvement, reaching a 50% decrease after 52 weeks of consecutive therapy. Source: UHC.
Can I use the Zepbound savings card with a UMR plan?
You may qualify when your coverage meets the card's terms. Lilly's commercial card excludes enrollment in government-funded programs such as Medicare or Medicaid. Working for a government employer is not the same thing as having Medicare or Medicaid. Check your actual coverage type and the card terms rather than rejecting the card based on your employer's name. Separate self-pay programs have separate rules. Source: Lilly's eligibility terms.
Does paying cash for Zepbound count toward my deductible?
Not under the specific LillyDirect and KwikPen self-pay offers described here, whose terms keep those purchases outside insurance. For a different cash purchase, ask the plan whether a claim can be submitted and check the discount program's terms before paying. Sources: Ro's LillyDirect terms and Lilly's self-pay card terms.
Can my employer drop Zepbound coverage?
Benefits can change. A past PA is not a guarantee that a later plan year will cover the drug. Read the benefit-change notice and ask the plan how it affects your prescription and any appeal rights. Source: the Michigan plan-change decision.
What is Lilly Employer Connect?
It's Lilly's employer access platform. Its announced KwikPen price to participating network pharmacies is $449 at every dose. Employee costs vary with employer support, fees, and program design. Your employer has to participate for its employer benefit to help you. Source: Lilly.
Is compounded tirzepatide covered by UMR?
A Zepbound benefit does not answer that question. Compounded tirzepatide is not FDA-approved Zepbound. Any coverage for a compounded prescription would need a separate check under your plan's compound-drug rules; it should not be billed or described as Zepbound. Source: FDA's explanation of unapproved GLP-1 products.
What we verified, and what we couldn't
We checked public documents and provider-stated services, not private member benefits or treatment outcomes. The comparison tables combine those sources so you can identify the right product, policy, and payment question. They do not predict your approval or replace your plan's formal decision and review process.
Provider-stated versus what we verified
| Claim or document | What we verified on September 22, 2026 | What this does not prove |
|---|---|---|
| UMR's role | UMR describes itself as a UnitedHealthcare company and a third-party administrator, not an insurer. | Your own Zepbound benefit or the pharmacy company your employer uses. |
| UHC policy examples | The retrieved policy text identifies P 1114-22 and P 1475-3, both effective September 1, 2026, with the program-specific requirements discussed above. | That your employer adopted either program. Exact sleep-study and A1c boundary values are not reproduced here; your prescriber needs the current policy issued for your group. |
| Optum's version split | July 1, 2026 Premium formulary entries, the code key, exception instructions, and the related quantity-limit list. We also checked the July and August update reports. | That every UMR plan uses this list, or that a Tier 2 listing guarantees payment. |
| Lilly's prices and cards | Published product-specific prices, savings caps, refill conditions, and Employer Connect's pharmacy-price basis. | Your final pharmacy bill, your card eligibility, or an employer contribution. |
| Ro's free report | Ro says it checks Zepbound pen coverage and PA requirements, but not the KwikPen. | A personally tested report, prescription, PA submission, or paid claim. |
| Ro's paid care | Published membership prices, insurance-support descriptions, refund rules, recurring billing, and cancellation terms. | Approval odds, a guaranteed turnaround, or a clinician's decision for you. |
| Sesame | Its weight-loss page offers clinician choice and PA support, with medication separate from care fees. Lilly names Sesame as an Employer Connect administrator. | An all-in quote for your chosen clinician and pharmacy, or participation by your employer. |
| Employer and public-decision examples | Pinellas County's benefit page, the University of Minnesota's product change, and the two cited Michigan decisions. | A national UMR rule or a prediction about your appeal. |
Sources: UMR, UHC weight-loss policy, UHC OSA policy, Optum Premium list, Lilly, Ro checker, Ro pricing, Ro terms, Sesame, and the employer and case sources below.
What we did not verify:
- Any reader's private plan, tier, copay, deductible, or medical eligibility
- Whether your employer uses UnitedHealthcare's example programs
- UMR-wide approval or appeal-success rates
- A completed enrollment, PA result, refund, or treatment outcome from Ro or Sesame
The call script, checklists, and cost arithmetic are our own tools for organizing the published information. They are not new clinical findings or a database of member claims.
Sources
Coverage and policy: UMR's member explanation · UHC weight-loss program · UHC OSA-only program · Optum July 2026 Premium formulary · Optum PA and quantity-limit list · Optum July update · Optum August update
Employers and plan examples: Pinellas County prescription plan · University of Minnesota's July 2026 change · KFF's 2025 employer survey · Lilly Employer Connect announcement
Medicine, prices, and safety: Zepbound prescribing information · FDA's OSA approval · LillyDirect prices · Lilly's full savings and self-pay terms · Mounjaro prescribing information · Wegovy prescribing information · FDA on unapproved GLP-1 products
Care services: Ro coverage checker · Ro pricing · Ro insurance process · Ro terms · Ro's attributed testimonial · Sesame's weight-loss program
Rights and payment rules: DOL claims and appeals guidance · HealthCare.gov external review · Texas Department of Insurance on self-funded plans · CMS COBRA guidance · CMS Medicare GLP-1 Bridge · CMS provider guidance · IRS Publication 502 · IRS Publication 969 · Michigan case 243954 · Michigan case 244942
Reader language: The original r/Zepbound discussion. These posts are personal reports, not coverage evidence.
Verification log — September 22, 2026: Checked the policy examples, product-specific formulary entries, public prices, savings restrictions, provider terms, and cited benefit and appeal examples. A verification date applies to the sources checked—not to any reader's private coverage.
This page is general information, not personal medical, legal, or insurance advice, and not a coverage decision. Treatment decisions belong to you and a licensed clinician. The RX Index may earn a commission from some provider links on this page. See our editorial standards.
Related guides: Does UMR Cover Wegovy? · OptumRx Zepbound Prior Authorization · Zepbound Savings Card · Best Insurance for Zepbound
Still not sure which GLP-1 program is right for you? Take our free matching quiz. Find My GLP-1 Path →